The 30+ pending buyouts of US listed Chinese companies are driven by the higher valuations available to similar businesses in the domestic Chinese equity market. But recent announcements demonstrate ways that companies can issue shares in China without undergoing privatization restructuring and relisting: Soufun will inject assets into an existing Shanghai listed shell company CNinsure … Continue reading US Listed Chinese companies are finding ways to access the Chinese Equity Market
Koneko Research 